


Anti-MERTK Recombinant Antibody Products

Anti-MERTK Products
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: WB, ELISA, IP
-
- Species Reactivity: Human
- Type: Mouse antibody
- Application: WB
- Recombinant Mouse Anti-MERTK Antibody (NEUT-1725CQ) (NEUT-1725CQ)
-
- Species Reactivity: Human
- Type: IgG
- Application: BL, WB, IP, IHC-P
- Mouse Anti-MERTK Recombinant Antibody (HPAB-0215-CN) (HPAB-0215-CN)
-
- Species Reactivity: Human, Mouse
- Type: Mouse IgG
- Application: WB, ELISA
- Mouse Anti-MERTK Recombinant Antibody (HPAB-0216-CN) (HPAB-0216-CN)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB, ELISA
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, IHC-P, IP
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB, ELISA
-
- Species Reactivity: Human
- Type: Humanized IgG4
- Application: ELISA
-
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: WB
- Mouse Anti-MERTK Recombinant Antibody (clone 7E5G1) (VS3-XY1063)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, WB
-
- Derivation: Rabbit
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, IHC, IP
-
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: ELISA, WB, IF, FC
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, IHC, IP
-
- Species Reactivity: Mouse
- Type: Rat IgG2a, κ
- Application: FC, FuncS, IF, IHC-Fr, WB, IP
- Mouse Anti-MERTK Recombinant Antibody; scFv Fragment (HPAB-0215-CN-S(P)) (HPAB-0215-CN-S(P))
-
- Species Reactivity: Human, Mouse
- Type: Mouse scFv
- Application: WB, ELISA
- Mouse Anti-MERTK Recombinant Antibody; scFv Fragment (HPAB-0216-CN-S(P)) (HPAB-0216-CN-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: WB, ELISA
- Mouse Anti-MERTK Recombinant Antibody; Fab Fragment (HPAB-0215-CN-F(E)) (HPAB-0215-CN-F(E))
-
- Species Reactivity: Human, Mouse
- Type: Mouse Fab
- Application: WB, ELISA
- Mouse Anti-MERTK Recombinant Antibody; Fab Fragment (HPAB-0216-CN-F(E)) (HPAB-0216-CN-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: WB, ELISA
- Mouse Anti-MERTK scFv-Fc Chimera (VS-0325-FY31) (VS-0325-FY31)
-
- Species Reactivity: Human
- Type: Mouse IgG1, scFv-Fc
- Application: Inhib
- Mouse Anti-MERTK Recombinant Antibody (clone 3D11G8) (VS7-0425-WR377)
-
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: WB, ICC, FC
-
- Species Reactivity: Human, Mouse
- Target: MERTK
- Host Animal: Mouse
- Application: ELISA, FC, Cell-uptake
- Anti-Mouse MERTK Immunohistochemistry Kit (VS-0525-XY4354)
-
- Species Reactivity: Mouse
- Target: MERTK
- Application: IHC
-
- Derivation: Phage display library screening
- Species Reactivity: Human
- Type: IgG
- Application: WB, IHC, IP, FC
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs offers advanced recombinant antibodies targeting MERTK, supporting the progress of biomedical research. Through cutting-edge technology platforms, we ensure each product upholds strict standards of quality and performance. Our broad portfolio reflects a strong commitment to research advancement, delivering reliable and cost-effective solutions. In addition to high-performance antibodies, we provide expert technical assistance to support scientists throughout their projects. Partnering with Creative Biolabs means gaining access to innovative tools and a dependable ally in your research efforts.
MERTK: A Crucial target in Autoimmune Disorders and Inflammatory Diseases
MERTK is a receptor tyrosine kinase that plays a critical role in immune regulation, tissue homeostasis, and the clearance of apoptotic cells. Dysregulation or overexpression of MERTK has been implicated in various diseases, including cancers such as leukemia and non-small cell lung cancer, as well as autoimmune and inflammatory disorders like systemic lupus erythematosus and rheumatoid arthritis. In cancer, MERTK contributes to tumor growth, survival, and resistance to therapy by promoting immune evasion and supporting oncogenic signaling pathways. In autoimmune diseases, improper MERTK signaling can impair the removal of dying cells, leading to chronic inflammation. Due to its involvement in both immune dysfunction and tumor progression, MERTK is considered a promising therapeutic target in oncology and immunology.
Alternative Names
Complement MERTK; MER proto-oncogene, tyrosine kinase; MER; RP38; c-Eyk; c-mer; Tyro12
Background
This gene is a member of the MER/AXL/TYRO3 receptor kinase family and encodes a transmembrane protein with two fibronectin type-III domains, two Ig-like C2-type (immunoglobulin-like) domains, and one tyrosine kinase domain. Mutations in this gene have been associated with disruption of the retinal pigment epithelium (RPE) phagocytosis pathway and onset of autosomal recessive retinitis pigmentosa (RP).
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets
Intracellular, Membrane (different isoforms)
Cell type enhanced (Astrocytes, Microglial cells, Kupffer cells, Macrophages)
Group enriched (intermediate monocyte, non-classical monocyte)
Cell line enhanced (CACO-2, Hep G2, HUVEC TERT2, RT4)
Interacts (upon activation) with TNK2; stimulates TNK2 autophosphorylation. Interacts (via N-terminus) with extracellular ligands LGALS3, TUB, TULP1 and GAS6 (By similarity). Interacts with VAV1 in a phosphotyrosine-independent manner. Interacts with TIMD4; this interaction enhances TIMD4-mediated efferocytosis (PubMed:32640697).
Kinase, Receptor, Transferase, Tyrosine-protein kinase
Anti-MERTK rAb Products
We are dedicated to advancing research and innovation by delivering high-quality anti-MERTK recombinant antibodies, combined with strong technical support and cost-effective solutions. Our goal is to help researchers move their projects forward efficiently and with confidence.
Cat. No. | Product Name | Target Species | Host Species | Applications |
MOB-4080z | Mouse Anti-MERTK Recombinant Antibody (clone 28A5) | Human | Mouse | WB; ELISA; IP |
MOB-1466MZ | Recombinant Mouse Anti-Human MERTK Antibody (clone B422G0H4) | Human | Mouse | WB |
NEUT-1725CQ | Recombinant Mouse Anti-MERTK Antibody (NEUT-1725CQ) | Human | Mouse | WB; Block; IP; IHC-P |
HPAB-0215-CN | Mouse Anti-MERTK Recombinant Antibody (HPAB-0215-CN) | Human; Mouse | Mouse | WB; ELISA |
ZG-0138U | Human Anti-MERTK Recombinant Antibody (clone 8H11) | Human | Human | ELISA |
Creative Quality Control
To support the advancement of biopharmaceutical research through to commercialization, we prioritize a customer-focused approach, emphasizing the delivery of high-quality products. A robust quality management system has been established to ensure consistency and reliability. By consistently meeting — and often exceeding — customer expectations, we strive to streamline the drug development process and help our clients reduce time to market.
Fig.1 ELISA analysis of anti-MERTK antibody
(Cat# ZG-0138U, Creative Biolabs).
Customer Reviews

Human Anti-MERTK Recombinant Antibody (clone 8H11) (CAT#: ZG-0138U)

Mouse Anti-MERTK Recombinant Antibody (clone 28A5) (CAT#: MOB-4080z)
rAb Production
With years of experience in recombinant antibody development and optimization, we are committed to delivering high-quality products and efficient service. Our focus on excellence ensures reliable recombinant antibodies within a short turnaround time.
Featured Anti-MERTK Recombinant Antibody Production Platforms
Fig.2 Milligram-scale recombinant antibody production.
Fig.3 Gram-scale recombinant antibody production.
rAb Modalities
Creative Biolabs provides researchers with a broad selection of advanced, high-quality recombinant antibodies in multiple formats. We specialize in diverse antibody engineering techniques and offer customized services to meet specific project requirements.
Fig.4 Full Length Anti-MERTK Recombinant Antibody Production and Modalities.
Drug Information Targeting MERTK
Table 1. Therapeutic approaches targeting MERTK in clinical development.
Research phase | Company | Classification | Indications | Details |
Phase III | Exelixis | Small Molecules | Cancer; Solid tumor | It is an oral next-generation tyrosine kinase inhibitor developed by Exelixis, currently in advanced clinical trials for various cancers, including metastatic colorectal cancer, non-clear cell renal cell carcinoma, and PD-L1 positive head and neck squamous cell carcinoma. |
Phase III | BeiGene | Small Molecules | Cancer; Solid tumor | It is an oral multitargeted kinase inhibitor developed by Mirati Therapeutics, licensed to BeiGene, and evaluated in clinical trials for various advanced solid tumors, including non-small cell lung cancer and urothelial carcinoma. |
Phase II | Lilly | Small Molecules | Cancer; Solid tumor | It is a human growth factor receptor inhibitor developed by Lilly, evaluated in clinical trials for various cancers including biliary tract adenocarcinoma and MET exon 14 mutant advanced non-small cell lung cancer. |
Phase I/II | Lead Discovery Center | Small Molecules | Cancer; Solid tumor | It is an orally available triple kinase inhibitor developed by Qurient, targeting Axl, Mer, and CSF1R for the treatment of advanced solid tumors, including esophageal and gastric cancers. |
Phase I/II | SignalChem Lifesciences | Small Molecules | Cancer; Solid tumor | It is an oral small-molecule AXL kinase inhibitor developed by SignalChem Lifesciences and Xuanzhu Biopharma for the treatment of advanced solid tumors, including non-small cell lung cancer and acute myeloid leukemia. |
Phase I | Ono | Small Molecules |
Acute leukemia; Cancer |
It is an oral AXL and MERTK dual inhibitor developed by Ono for the treatment of EGFR-positive non-small cell lung cancer and pancreatic cancer. |
Phase I | King Faisal Specialist Hosp Res Centre | Biologics | Retinitis pigmentosa | It is a gene therapy using rAAV2 encoding human MERTK, developed by KFSHRC for the treatment of retinitis pigmentosa. |
If you need more details about the MERTK target, don't hesitate to contact us by phone or email. Our experienced team is happy to help with any questions or issues you encounter, providing the support necessary for your research success.